In this article
AgelessRx discusses GLP-1 treatment alongside longevity and microdosing offerings. A comparison for weight management should begin with the specific treatment goal and prescription being considered, rather than treating those categories as interchangeable.
The current starting GLP-1 price is tied to a four-month plan, with other terms available. This guide compares alternative care models and the questions that help separate a promotional term from a long-term treatment decision.
Specify the treatment goal, exact product, evidence for that product, and the full plan commitment. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Specify the treatment goal, exact product, evidence for that product, and the full plan commitment.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Specify the treatment goal, exact product, evidence for that product, and the full plan commitment. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our sponsored comparison for a self-pay weight-management pathway. Consider the prescribed GLP-1 plan on its own merits rather than treating other products in the catalog as required additions.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. Henry Meds
A bundled-care comparison with product- and dose-dependent pricing. Its own distinction between compounded formulations and approved-drug evidence is worth reading closely.
The weight-management FAQ lists GLP-1 treatment starting at $179 per month, with price varying by plan and dose. It describes the amount as including provider visits, medication, and supplies. The starting figure is not a quote for every medication, route, or dose.
Henry says it works with licensed U.S. compounding pharmacies. The reviewed FAQ does not establish the identity and state authorization of every possible dispenser. Ask for the actual pharmacy attached to your prescription.
Continue with our Henry Meds review and pricing details.
03. Mochi Health
A membership-plus-medication model for continuing care. Compare the current dose-based medicine price and recurring membership together.
Mochi advertises a $39 first membership month for eligible new subscribers and a $79 ongoing monthly membership. Its August 2026 pricing explanation describes dose-based compounded semaglutide prices of $60–$99 and tirzepatide prices of $90–$199, with medication billed separately.
Mochi’s pricing article says its transition to dose-based prices did not change the pharmacies or additives for the plans discussed. It does not identify your personal dispensing pharmacy. Confirm the pharmacy and complete formulation shown in your own care plan.
Continue with our Mochi Health review and pricing details.
04. Ro
A relevant alternative for discussing FDA-approved branded products and insurance assistance. Approval of a product still does not determine its suitability for an individual.
Ro lists $39 for the first Body membership month, then $149 on a month-to-month plan, or an advertised monthly equivalent as low as $74 with annual prepayment. The cost of the medication is excluded.
For an insured prescription, Ro describes sending it to a pharmacy; cash-pay routes can differ. Confirm the pharmacy and whether your prescribed product is a manufacturer-labeled medicine. Do not use an old compounded-pricing article to identify the product in a new Ro checkout.
Continue with our Ro review and pricing details.
05. Sesame Care
An alternative organized around recurring provider visits and a separate medication bill. The shorter commitment can be evaluated against the lower annual-plan care rate.
Success by Sesame lists care from $59 per month on a 12-month commitment and a $99 month-to-month option. Medication costs are excluded and vary with the prescription, pharmacy, and coverage.
Read the selected plan’s refund and renewal cutoff. Its FAQ distinguishes cancelling before the initial visit from a cancellation after that visit has occurred.
Check the official Sesame Care program page for the current offer and conditions.
06. NexLife
A fully online comparison with published starting prices and a cancellation notice period. Confirm the selected term and required notice rather than relying on a general flexibility statement.
NexLife lists semaglutide starting at $139 and tirzepatide at $169 per month. A separate $119 headline is tied to a 12-month plan, so these numbers should not be treated as interchangeable offers.
The FAQ says there is no minimum commitment but requests 30 days’ notice for cancellation, with possible review in certain medical circumstances. Ask how that notice period affects the next payment.
Check the official NexLife program page for the current offer and conditions.
The current AgelessRx baseline
AgelessRx advertises GLP-1 plans starting at $139 per month, with that starting price tied to a four-month plan. It also lists monthly and two-month arrangements.
The GLP-1 page describes clinician review, ongoing care, and compounded products from licensed pharmacies. It markets both conventional weight-management and microdosing approaches.
Ask what exact formulation and treatment goal are proposed. Marketing about longevity or microdosing is not equivalent to an FDA-approved indication or proof of a longer life.
The details that decide this comparison
Ask whether the proposed use and formulation have evidence for your actual treatment goal. Marketing a lower dose does not establish a separate approved indication.
A four-month monthly equivalent should be compared with another four-month total, including required care charges.
If you receive other prescriptions through a longevity service, give the weight-management clinician a complete medication and supplement list. A shared storefront is not proof that products should be combined.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
Ask the clinician to explain the purpose of each prescribed product and how progress will be reviewed. Weight management, diabetes treatment, and speculative longevity goals require different conversations.
If changing services, transfer the actual treatment history rather than a marketing label such as “microdose.” The receiving clinician needs the product, concentration, prescribed instructions, and response.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- GLP-1 Weight Loss Treatment | HenryProvider-published information · Checked September 21, 2026
- Online Medical Weight Loss Program | Mochi HealthProvider-published information · Checked September 21, 2026
- Mochi: August 2026 dose-based pricingProvider-published information · Checked September 21, 2026
- Contact us | Mochi HealthProvider-published information · Checked September 21, 2026
- Weight Loss - Ro Body Membership | RoProvider-published information · Checked September 21, 2026
- Ro - Telehealth for ED, Hair loss, Skincare, Fertility and MoreProvider-published information · Checked September 21, 2026
- Sesame Care: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- NexLife: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- AgelessRx: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction